Bloodstream infection after elective liver transplantation is associated with increased mortality in patients with cirrhosis

Journal of Critical Care

Volumn 26, Issue 5, 2011, Pages 468-474

  Karvellas, Constantine J ^a,b   McPhail, Mark ^b   Pink, Fred ^b   Asthana, Sonal ^a   Muiesan, Paolo ^c   Heaton, Nigel ^b   Auzinger, Georg ^b   Bernal, William ^b   Eltringham, Ian ^b   Wendon, Julia A ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bacteremia; Bloodstream infection; Chronic liver disease; Liver transplantation; Sepsis

Indexed keywords

ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; FUNGEMIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; BACTEREMIA; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053449640     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.12.018     Document Type: Article

References (25)

1. Adams H.G., Jordan C. Infections in the alcoholic. Med Clin North Am 1984, 68:179-200.
2. Wyke R.J. Problems of bacterial infection in patients with liver disease. Gut 1987, 28:623-641.
3. Johnson D.H., Cunha B.A. Infections in cirrhosis. Infect Dis Clin North Am 2001, 15:363-371. vii.
4. Campbell A.C., Dronfield M.W., Toghill P.J., et al. Neutrophil function in chronic liver disease. Clin Exp Immunol 1981, 45:81-89.
5. Fierer J., Finley F. Deficient bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest 1979, 63:912.
6. Liu Y.K. Effects of alcohol on granulocytes and lymphocytes. Semin Hematol 1980, 17:130-136.
7. Fortun J., Martin-Davila P., Moreno S., et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002, 8:1065-1070.
8. Singh N., Wagener M.M., Obman A., et al. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004, 10:844-849.
9. Gavalda J., Len O., San Juan R., et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 2005, 41:52-59.
10. Wade J.J., Rolando N., Hayllar K., et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995, 21:1328-1336.
11. Kusne S., Dummer J.S., Singh N., et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988, 67:132-143.
12. Wagener M.M., Yu V.L. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992, 20:239-247.
13. Singh N., Arnow P.M., Bonham A., et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997, 64:716-720.
14. Bert F, Larroque B, Paugam-Burtz C, et al.: Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl 16:393-401.
15. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
16. Wiesner R., Edwards E., Freeman R., et al. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96.
17. Document N. Nosocomial Infection National Surveillance Scheme (UK): protocol for the surveillance of hospital acquired bacteremia 1997, PHLS Central Public Health Laboratory, London.
18. Fortun J., Martin-Davila P., Moreno S., et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother 2003, 52:813-819.
19. Yamamoto S., Sato Y., Oya H., et al. Risk factors and prevention of biliary anastomotic complications in adult living donor liver transplantation. World J Gastroenterol 2007, 13:4236-4241.
20. Patel R., Badley A.D., Larson-Keller J., et al. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 1996, 61:1192-1197.
21. Maki D.G., Agger W.A. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988, 67:248-269.
22. Laupland K.B., Kirkpatrick A.W., Church D.L., et al. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect 2004, 58:137-145.
23. Park D.R. The microbiology of ventilator-associated pneumonia. Respir Care 2005, 50:742-763. [discussion 763-745].
24. Kim S.I., Kim Y.J., Jun Y.H., et al. Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J 2009, 50:112-121.
25. Smith J.O., Shiffman M.L., Behnke M., et al. Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes. Liver Transpl 2009, 15:273-279.